Our day one keynote featured Dr. Albert Bourla, Chairman and CEO of Pfizer Inc. (#PFE), and was moderated by Louise Chen.
• The discussion focused on PFE’s leading vaccine portfolio, including Comirnaty, Prevnar 20, Abryvso, a potential mRNA flu vaccine, among other opportunities in pediatric, adult, and older populations.
• We reviewed the market opportunity for obesity, and how danuglipron would fit into the treatment paradigm with its upcoming data readout.
• Dr. Bourla also shared with us his view on the M&A market, as well as the IRA/Medicare price negotiation’s impact on the industry.
#Cantor #CantorFitzgerald #CantorHealthcare #CantorGlobalHealthcare2023